Nebraska Hematology-Oncology /ID# 269692 — Lincoln, Nebraska

Nebraska Hematology-Oncology /ID# 269692 is a clinical research site located in Lincoln, Nebraska, United States 68506.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Nebraska Hematology-Oncology /ID# 269692 has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Follicular Lymphoma (FL), Non-Small Cell Lung Cancer.

Sponsors: Genmab, AbbVie.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Lincoln

Browse all research sites in Nebraska · View every site in Lincoln

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Hematology-Oncology /ID# 269692?

Nebraska Hematology-Oncology /ID# 269692 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Hematology-Oncology /ID# 269692 conducted?

Nebraska Hematology-Oncology /ID# 269692 has 2 clinical trials on record, with 2 currently active. Their work covers Follicular Lymphoma (FL), Non-Small Cell Lung Cancer.

Is Nebraska Hematology-Oncology /ID# 269692 accredited by Crixeo Clinical Trials?

Nebraska Hematology-Oncology /ID# 269692 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nebraska Hematology-Oncology /ID# 269692?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.